Development and Validation of Models to Predict Functional Cure in Patients With CHB After Peg-IFN Based Therapy

RecruitingOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

January 6, 2024

Primary Completion Date

July 31, 2024

Study Completion Date

December 31, 2025

Conditions

Hepatitis B, Chronic

Interventions

DRUG

Peginterferon-α; Nucleoside analogs

Patients with chronic hepatitis B were treated with the combination of peginterferon-α and nucleoside analogs

Trial Locations (1)

RECRUITING

Qilu hospital of Shandong University, Jinan

All Listed Sponsors

lead

Qilu Hospital of Shandong University

OTHER